The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial

OBJECTIVES: Our objective was to evaluate whether vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) prevents the incidence of community-acquired pneumonia (CAP) caused by influenza (influenza-associated CAP, IA-CAP) or other respiratory viruses in the elderly. METHODS: This analy...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Microbiol Infect
Auteurs principaux: Huijts, S.M., Coenjaerts, F.E.J., Bolkenbaas, M., van Werkhoven, C.H., Grobbee, D.E., Bonten, M.J.M.
Format: Artigo
Langue:Inglês
Publié: The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7129545/
https://ncbi.nlm.nih.gov/pubmed/29050992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2017.10.006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires